Literature DB >> 1458560

Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects.

H Kobayashi1, Y Takemura, T Ohnuma.   

Abstract

When tumor cell density increases, the cytotoxic activity of certain anticancer agents, such as vincristine (VCR) and doxorubicin (DXR), progressively decreases. This phenomenon is termed the inoculum effect. Since VCR and DXR are less active in an acidic environment, we questioned whether the inoculum effects could have resulted from acidification of the medium that may have developed due to the high cell density. However, measurements of the cytotoxic activity of these agents in a pH-controlled medium revealed only a minor correction of the inoculum effects. Second, we wondered whether the inoculum effects that occurred at the high cell density might have been attributable to insufficient amounts of drugs to bind all the binding sites of the cells. To test this hypothesis, we used drug-resistant sublines, which required higher VCR or DXR concentrations for cell killing than did the parent cell line. When higher drug concentrations were used, the dose-response curves generated for low- and high-density cell populations became closer and overlapped each other, resulting in virtual disappearance of the inoculum effects. Measurements of cellular drug levels revealed that at a high cell density, cells accumulated much smaller amounts of both VCR and DXR in parallel with the positive inoculum effect. In contrast, when high concentrations of the drugs were used in drug-resistant cells, differences in the cellular drug contents between low and high cell densities became narrow. Cisplatin (DDP) belongs to a group of drugs that do not produce inoculum effects, and DDP's cytotoxic effects were not influenced by the pH-controlled medium or by the use of drug-resistant cell lines. These observations indicate that the inoculum effects are the result of the unavailability of VCR or DXR molecules to all cellular binding sites when cells at high densities are exposed to drugs. The drug concentration relative to cell density was apparently the major determinant for the inoculum effects seen in VCR- or DXR-induced cell killing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458560     DOI: 10.1007/bf00695987

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.

Authors:  H Arkin; T Ohnuma; B A Kamen; J F Holland; S Vallabhajosula
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

2.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

Review 4.  The anthracycline antineoplastic drugs.

Authors:  R C Young; R F Ozols; C E Myers
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

5.  Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.

Authors:  T S Herman; B A Teicher; L S Collins
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

6.  The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro.

Authors:  Y Takemura; H Kobayashi; H Miyachi; K Hayashi; S Sekiguchi; T Ohnuma
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.

Authors:  M J Basker; R A Edmondson; R Sutherland
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.

Authors:  A A Hindenburg; J E Gervasoni; S Krishna; V J Stewart; M Rosado; J Lutzky; K Bhalla; M A Baker; R N Taub
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

9.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

10.  Vindesine receptors in cells of a human leukaemia cell line.

Authors:  K Totsuka; K Oshimi; H Mizoguchi
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

View more
  13 in total

1.  Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer.

Authors:  Joel S Brown; Jessica J Cunningham; Robert A Gatenby
Journal:  IEEE Trans Biomed Eng       Date:  2016-11-01       Impact factor: 4.538

2.  Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia.

Authors:  Alex Bogason; Angelica L Quartino; Pierre Lafolie; Michèle Masquelier; Mats O Karlsson; Christer Paul; Astrid Gruber; Sigurd Vitols
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

3.  Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.

Authors:  Stephanie L Ham; Ramila Joshi; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2016-09-07       Impact factor: 9.933

4.  Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.

Authors:  H Kobayashi; Y Takemura; H Miyachi; M Kawabata; S Mori; Y Kawai; K Furihata; S Sekiguchi; K Watanabe
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

5.  High-content imaging assays on a miniaturized 3D cell culture platform.

Authors:  Pranav Joshi; Akshata Datar; Kyeong-Nam Yu; Soo-Yeon Kang; Moo-Yeal Lee
Journal:  Toxicol In Vitro       Date:  2018-03-06       Impact factor: 3.500

6.  The Chemistry and Biology of Nakiterpiosin - C-nor-D-Homosteroids.

Authors:  Shuanhu Gao; Qiaoling Wang; Gelin Wang; Brett Lomenick; Jie Liu; Chih-Wei Fan; Lih-Wen Deng; Jing Huang; Lawrence Lum; Chuo Chen
Journal:  Synlett       Date:  2012-10       Impact factor: 2.454

7.  High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).

Authors:  Itsuki Yamaguchi; Shige H Yoshimura; Hironori Katoh
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

8.  Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio.

Authors:  Paul L Chariou; Karin L Lee; Jonathan K Pokorski; Gerald M Saidel; Nicole F Steinmetz
Journal:  J Phys Chem B       Date:  2016-04-13       Impact factor: 2.991

9.  Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3.

Authors:  Tomoyoshi Komiyama; Atsushi Ogura; Takatsugu Hirokawa; Miao Zhijing; Hiroshi Kamiguchi; Satomi Asai; Hayato Miyachi; Hiroyuki Kobayashi
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

10.  Effect of hammerhead ribozyme against human thymidylate synthase on the cytotoxicity of thymidylate synthase inhibitors.

Authors:  H Kobayashi; Y Takemura; H Miyachi; L Skelton; A L Jackman
Journal:  Jpn J Cancer Res       Date:  1995-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.